Nalaganje...
The clinical utility of aflibercept for diabetic macular edema
The treatment of center-involving diabetic macular edema (DME) has improved because of the proven efficacy of drugs that inhibit the effects of vascular endothelial growth factor (VEGF). The newest anti-VEGF drug, aflibercept, has recently been approved by the United States Food and Drug Administrat...
Shranjeno v:
| izdano v: | Diabetes Metab Syndr Obes |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4583120/ https://ncbi.nlm.nih.gov/pubmed/26425104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S72792 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|